Nosology of genetic skeletal disorders: 2023 revision
American Journal of Medical Genetics Part A · 2023-05 · 191 (5) · 1164-1209
DOI: 10.1002/ajmg.a.63132 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 13.02.2023. Verfasst von Sheila Unger und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetic Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Die Arbeit wurde bisher 394-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wellcome Trust, DBT-Wellcome Trust India Alliance, Intramural NIH HHS.
Abstract (Originalsprache)
The “Nosology of genetic skeletal disorders” has undergone its 11th revision and now contains 771 entries associated with 552 genes reflecting advances in molecular delineation of new disorders thanks to advances in DNA sequencing technology. The most significant change as compared to previous versions is the adoption of the dyadic naming system, systematically associating a phenotypic entity with the gene it arises from. We consider this a significant step forward as dyadic naming is more informative and less prone to errors than the traditional use of list numberings and eponyms. Despite the adoption of dyadic naming, efforts have been made to maintain strong ties to the MIM catalog and its historical data. As with the previous versions, the list of disorders and genes in the Nosology may be useful in considering the differential diagnosis in the clinic, directing bioinformatic analysis of next‐generation sequencing results, and providing a basis for novel advances in biology and medicine.
Autor:innen und Institutionen
- Division of Genetic Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
- Skeletal Genomics Unit, Metabolic Medicine Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
- Center for Human Genetics, University Hospital Leuven and KU Leuven, Leuven, Belgium.
- INSERM, US14-Orphanet, Paris, France.
- Unidade de Genética, Instituto da Criança, Hospital das Clínicas da Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
- Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil.
ORCID-Profile: Débora R Bertola, Daniel H Cohn, Katta M Girisha, Deborah Krakow, Outi Makitie, Stephen P Robertson, Andrea Superti-Furga
Förderung
- Wellcome Trust
- DBT-Wellcome Trust India Alliance
- Intramural NIH HHS
- Université de Lausanne
- The Wellcome Trust DBT India Alliance
- Sigrid Juséliuksen Säätiö
Zitieren
APA
Unger, S., Ferreira, C. R., Mortier, G. R., Ali, H., Bertola, D. R., Calder, A., Cohn, D. H., Cormier-Daire, V., Girisha, K. M., Hall, C., Krakow, D., Makitie, O., Mundlos, S., Nishimura, G., Robertson, S. P., Savarirayan, R., Sillence, D., Simon, M., Sutton, V. R., …, & Superti-Furga, A. (2023). Nosology of genetic skeletal disorders: 2023 revision. American Journal of Medical Genetics Part A, 191(5), 1164-1209. https://doi.org/10.1002/ajmg.a.63132
Vancouver
Unger S, Ferreira CR, Mortier GR, Ali H, Bertola DR, Calder A, et al. Nosology of genetic skeletal disorders: 2023 revision. American Journal of Medical Genetics Part A. 2023;191(5):1164-1209. doi:10.1002/ajmg.a.63132
BibTeX
@article{Unger2023,
author = {Unger, Sheila and Ferreira, Carlos R and Mortier, Geert R and Ali, Houda and Bertola, Débora R and Calder, Alistair and Cohn, Daniel H and Cormier-Daire, Valerie and Girisha, Katta M and Hall, Christine and Krakow, Deborah and Makitie, Outi and Mundlos, Stefan and Nishimura, Gen and Robertson, Stephen P and Savarirayan, Ravi and Sillence, David and Simon, Marleen and Sutton, V Reid and Warman, Matthew L and Superti-Furga, Andrea},
title = {Nosology of genetic skeletal disorders: 2023 revision},
journal = {American Journal of Medical Genetics Part A},
year = {2023},
volume = {191},
number = {5},
pages = {1164--1209},
doi = {10.1002/ajmg.a.63132}
}
EUVIMED